Back to search

Article

Are the common genetic 3’UTR variants in ADME genes playing a role in tolerance of breast cancer chemotherapy?

2022-12-05

Abstract excerpt

We described associations among 3’UTR genetic variants in ADME genes, clinical factors and the risk of toxicity or side effects of breast cancer chemotherapy. The SNPs in breast cancer women were tested in relation to 12 symptoms belonging to myelotoxicity (anemia, leukopenia, neutropenia), gastrointestinal side effects (vomiting, nausea), nephrotoxicity and hepatotoxicity, occurred in overall, early or recurrent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c946971-58a3-58de-bf3b-69141bdc07c7
DOI
10.21203/rs.3.rs-2185723/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Are the common genetic 3’UTR variants in ADME genes playing a role in tolerance of breast cancer chemotherapy?DOI 10.21203/rs.3.rs-2185723/v1
Are the Common Genetic 3'UTR Variants in ADME Genes Playing a Role in Tolerance of Breast Cancer Chemotherapy?Semantic proximity
Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients.Semantic proximity
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patientsSemantic proximity
Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) RegimenSemantic proximity
Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.Semantic proximity
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience.Semantic proximity
Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy.Semantic proximity
The incidence of adjuvant chemotherapy-related early-onset cardiac events in breast cancer patients and its relationship with genetic susceptibility: A prospective cohort studySemantic proximity
Risk for relapse and death after adjuvant chemotherapy associated with SNPs in patients with breast cancer - A retrospective study.Semantic proximity
Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo- or Adjuvant Chemotherapy: A Randomised Multicentre Phase II Study. (EudraCT: 2015-000658-39).Semantic proximity
Influence of (C1236T and C3435T) Polymorphisms of ABCB1 Gene on Chemotherapy Treatment Outcome and Toxicity in Breast Cancer Patients.Semantic proximity
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclibSemantic proximity
Select a neighboring publication to make it the new centre.